TG Therapeutics reported Q3 2026 revenue of US$259.94 million and net income of US$55.46 million, and raised full year 2026 global revenue guidance to about US$1b. The stronger outlook is tied closely...
Source LinkTG Therapeutics reported Q3 2026 revenue of US$259.94 million and net income of US$55.46 million, and raised full year 2026 global revenue guidance to about US$1b. The stronger outlook is tied closely...
Source Link
Comments